Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Current experimental therapy.

S M Cotter

    The Veterinary Clinics of North America. Small Animal Practice
    |July 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Successful experimental therapy for canine hematopoietic tumors requires homogeneous patient groups and cost-effective drug combinations. Preventing drug resistance is crucial for effective treatment outcomes in dogs.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    A retrospective assessment of the completeness and timeliness of meningococcal disease notifications in the Republic of Ireland over a 16-year period, 1999-2015.

    Public health·2018
    Same author

    Lack of evidence of pregnancy-induced alloantibodies in dogs.

    Journal of veterinary internal medicine·2009
    Same author

    Treatment of vascular and soft-tissue sarcomas in dogs using an alternating protocol of ifosfamide and doxorubicin.

    Veterinary and comparative oncology·2009
    Same author

    A combination chemotherapy protocol with MOPP and CCNU consolidation (Tufts VELCAP-SC) for the treatment of canine lymphoma.

    Veterinary and comparative oncology·2009
    Same author

    Efficacy and toxicosis of VELCAP-C treatment of lymphoma in cats.

    Journal of veterinary internal medicine·2008
    Same author

    Mushroom-derived maitake PETfraction as single agent for the treatment of lymphoma in dogs.

    Journal of veterinary internal medicine·2008
    Same journal

    Regulation of Artificial Intelligence in Veterinary Medicine.

    The Veterinary clinics of North America. Small animal practice·2026
    Same journal

    Practical Steps Toward Antimicrobial Stewardship for the General Practitioner.

    The Veterinary clinics of North America. Small animal practice·2026
    Same journal

    Using Evidence-Based Veterinary Medicine and Artificial Intelligence to Support Clinical Decision Making in Veterinary Practice.

    The Veterinary clinics of North America. Small animal practice·2026
    Same journal

    Feline Asthma-Update on Diagnosis and Treatment Recommendations.

    The Veterinary clinics of North America. Small animal practice·2026
    Same journal

    Disease Prediction and Precision Veterinary Medicine: Applications, Opportunities, and Limitations of Artificial Intelligence in Small Animal Practice.

    The Veterinary clinics of North America. Small animal practice·2026
    Same journal

    The Moving Target of Companion Animal Infectious Diseases: Emerging Threats and Evolving Solutions.

    The Veterinary clinics of North America. Small animal practice·2026
    See all related articles

    Area of Science:

    • Veterinary Oncology
    • Comparative Oncology
    • Hematopoietic Malignancies

    Background:

    • Canine hematopoietic tumors present a significant challenge in veterinary medicine.
    • Developing effective experimental therapies requires careful patient selection and treatment design.

    Purpose of the Study:

    • To outline essential criteria for successful experimental therapy of canine hematopoietic tumors.
    • To identify key components for effective treatment regimens, including drug combinations and supportive modalities.

    Main Methods:

    • Review of principles for experimental therapeutic design in veterinary oncology.
    • Consideration of patient population characteristics, drug selection, and combination strategies.
    • Exploration of adjunctive therapies such as biological response modifiers, radiation, and stem cell transplantation.

    Related Experiment Videos

    Main Results:

    • Successful therapy necessitates randomized, homogeneous patient populations in good condition.
    • Drug combinations should feature agents with antitumor activity, manageable toxicity, and reasonable cost.
    • Preventing drug resistance in tumor cells is a critical factor for therapeutic success.

    Conclusions:

    • A multi-faceted approach combining optimized drug regimens with other modalities is essential.
    • Further research into preventing drug resistance is vital for advancing canine cancer treatment.
    • Standardized protocols are needed for reproducible and effective experimental cancer therapies in dogs.